201. Angelman syndrome
19 clinical trials,   30 drugs   (DrugBank: 7 drugs),   22 drug target genes,   20 drug target pathways

Searched query = "Angelman syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03235037
(ClinicalTrials.gov)
November 26, 201328/7/2017Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man SyndromeClinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man SyndromeAngelman SyndromeDrug: LevodopaBennett LavensteinNULLCompleted18 Months16 YearsAll10N/ANULL
2NCT01281475
(ClinicalTrials.gov)
January 201120/1/2011A Trial of Levodopa in Angelman SyndromeA Phase 2 Randomized Placebo-Controlled Trial of Levodopa in Angelman SyndromeAngelman SyndromeDrug: Levodopa;Drug: Placebo Oral CapsuleWen-Hann TanRady Children's Hospital, San Diego;University of California, San Francisco;Baylor College of Medicine;Vanderbilt University Medical Center;Greenwood Genetic Center;Children's Hospital Medical Center, Cincinnati;Angelman Syndrome Foundation, Inc.Completed4 Years12 YearsAll67Phase 2;Phase 3United States
3NCT00829439
(ClinicalTrials.gov)
January 200926/1/2009Study on Tolerability of Levodopa/Carbidopa in Children With Angelman SyndromeA Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman SyndromeAngelman SyndromeDrug: Levodopa/Carbidopa (4:1)Boston Children’s HospitalNULLCompleted4 Years12 YearsAll16Phase 1United States